ES8700850A1 - 1,4-dihidropiridin-carboxiamidas. - Google Patents

1,4-dihidropiridin-carboxiamidas.

Info

Publication number
ES8700850A1
ES8700850A1 ES549873A ES549873A ES8700850A1 ES 8700850 A1 ES8700850 A1 ES 8700850A1 ES 549873 A ES549873 A ES 549873A ES 549873 A ES549873 A ES 549873A ES 8700850 A1 ES8700850 A1 ES 8700850A1
Authority
ES
Spain
Prior art keywords
dihydropyridine
medicaments
preparation
carboxylic acid
acid amides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549873A
Other languages
English (en)
Other versions
ES549873A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8700850A1 publication Critical patent/ES8700850A1/es
Publication of ES549873A0 publication Critical patent/ES549873A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,4-DIHIDROPIRIDIN-CARBOXAMIDAS DE FORMULA GENERAL (I). SE HACEN REACCIONAR ALDEHIDOS DE FORMULA GENERAL R5 CHFO CON ENAMINAS DE FORMULA GENERAL (II). ESTOS COMPUESTOS PUEDEN EMPLEARSE PARA COMBATIR LAS ENFERMEDADES DEL SISTEMA CIRCULATORIO Y LA TROMBOSIS.
ES549873A 1984-12-15 1985-12-12 1,4-dihidropiridin-carboxiamidas. Expired ES8700850A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843445852 DE3445852A1 (de) 1984-12-15 1984-12-15 Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES8700850A1 true ES8700850A1 (es) 1986-11-16
ES549873A0 ES549873A0 (es) 1986-11-16

Family

ID=6252899

Family Applications (4)

Application Number Title Priority Date Filing Date
ES549873A Expired ES8700850A1 (es) 1984-12-15 1985-12-12 1,4-dihidropiridin-carboxiamidas.
ES556986A Expired ES8801207A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas
ES556988A Expired ES8801208A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4 dihidropiridincarboxiamidas
ES556987A Expired ES8707501A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES556986A Expired ES8801207A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas
ES556988A Expired ES8801208A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4 dihidropiridincarboxiamidas
ES556987A Expired ES8707501A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas

Country Status (11)

Country Link
US (1) US4707479A (es)
EP (1) EP0185964B1 (es)
JP (1) JPH0631224B2 (es)
AT (1) ATE50571T1 (es)
AU (1) AU5107085A (es)
CA (1) CA1259996A (es)
DE (2) DE3445852A1 (es)
DK (1) DK578485A (es)
ES (4) ES8700850A1 (es)
HU (1) HUT40081A (es)
ZA (1) ZA859550B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (es) * 1986-04-11 1989-02-04 Hoechst India
DE3712369A1 (de) * 1987-04-11 1988-10-27 Bayer Ag Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
DE3712371A1 (de) * 1987-04-11 1988-10-27 Bayer Ag Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
DE3724909A1 (de) * 1987-07-28 1989-02-09 Bayer Ag Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
DE3833892A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3991589T1 (de) * 1989-02-17 1991-02-21 Inst Organicheskogo Sinteza Ak Basische salze der 2-(2,6-diemthyl-3,5-diaethoxykarboonyl-1,4-dihydropyridin-4-karboxamido)aethansulfonsaeure und verfahren zur herstellung derselben
CA2069877A1 (en) * 1990-10-02 1992-04-03 Michio Nakanishi Ethynylphenyl derivative substituted by pyridazinone and medicament for circulatory disease containing the same as an effective ingredient
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
DE4118707A1 (de) * 1991-06-07 1992-12-10 Bayer Ag Pharmazeutische verwendung von 3-formyl-1,4-dihydropyridinen, neue verbindungen und verfahren zu ihrer herstellung
DE4202526A1 (de) * 1992-01-30 1993-08-05 Bayer Ag Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE50103978D1 (de) * 2000-02-04 2004-11-11 Lonza Ag Verfahren zur herstellung von acetoacetylierten aromatischen aminen
PL376405A1 (en) 2002-10-07 2005-12-27 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
WO2018086703A1 (en) 2016-11-11 2018-05-17 Bayer Pharma Aktiengesellschaft Dihydropyridazinones substituted with phenylureas
EP3746079A1 (en) 2018-01-31 2020-12-09 Bayer Aktiengesellschaft Antibody drug conjugates (adcs) with nampt inhibitors
WO2021013693A1 (en) 2019-07-23 2021-01-28 Bayer Pharma Aktiengesellschaft Antibody drug conjugates (adcs) with nampt inhibitors
WO2022114187A1 (ja) * 2020-11-30 2022-06-02 国立大学法人九州大学 ミトコンドリア過剰分裂阻害作用を有する化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0107735B1 (en) * 1981-10-20 1988-10-19 Mitsui Toatsu Kagaku Kabushiki Kaisha Novel pyridazinone derivatives
DE3319956A1 (de) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
DE3445852A1 (de) 1986-06-19
EP0185964A3 (en) 1986-12-03
EP0185964A2 (de) 1986-07-02
HUT40081A (en) 1986-11-28
DE3576156D1 (de) 1990-04-05
AU5107085A (en) 1986-06-19
US4707479A (en) 1987-11-17
EP0185964B1 (de) 1990-02-28
ES556986A0 (es) 1987-12-16
ZA859550B (en) 1986-08-27
ATE50571T1 (de) 1990-03-15
ES556988A0 (es) 1987-12-16
CA1259996A (en) 1989-09-26
ES8801207A1 (es) 1987-12-16
ES556987A0 (es) 1987-08-01
ES8801208A1 (es) 1987-12-16
JPH0631224B2 (ja) 1994-04-27
ES8707501A1 (es) 1987-08-01
DK578485D0 (da) 1985-12-13
JPS61145180A (ja) 1986-07-02
DK578485A (da) 1986-06-16
ES549873A0 (es) 1986-11-16

Similar Documents

Publication Publication Date Title
ES8700850A1 (es) 1,4-dihidropiridin-carboxiamidas.
MY103352A (en) Piperazinyl-heterocyclic compounds
NO894995D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive anionebytter-polymerer.
DE3374407D1 (en) Dihydropyrimidines, process for their preparation and their use in medicaments
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
IL72354A0 (en) Imidazolium salts,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3572820D1 (en) 1,4:3,6-dianhydro-hexite derivatives, process for their preparation and their use as medicaments
GR74978B (es)
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
BR8806062A (pt) Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis
ES472435A1 (es) Procedimiento para la preparacion de derivados de 4-hidroxi-2-bancimidazolinona
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
HUT44515A (en) Process for producing isoquinolinol compounds of heart activity increasing, phosphodiesterase iii inhibiting and/or renal vasodilating activity and pharmaceutical composition containing them
IT1230140B (it) Derivati della serina, loro processo di preparazione e impiego in terapia umana
ATE40687T1 (de) Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ZA872863B (en) 1,4-dihydropyridine derivatives,process for their preparation and medicaments containing these compounds
HUT44802A (en) Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them
IT1149399B (it) Procedimento per la produzione di 4-metossi-2'-/2-(1-metil-2-piperidil)etil/benzanilide avente attiva' di regolazione del ritmo cardiaco
JPS6490158A (en) 1,2-diamino compound, manufacture and medicine for treating cardiac disease and circulatory disease
HU9201316D0 (en) Process for the production of hiv treating medical preparation containing 9-amino-1,2,3,4 tetrahydro-acridine-1-ol derivatives as active agents
DE3689086T2 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzung und ihre Verwendung.
UA7216A1 (uk) Спосіб одержання похідних 12-аміно-пірідазіно[4', 5':3,4]-пірроло[2,1-а] ізохіноліна або їх фізіологічно переносимих кислотно-аддітивних солей